BSE · 531380
Centenial Surgical Suture Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹54 Cr with net profit ₹-1 Cr — a -2.73% net margin, versus 2.21% the period before.
Shareholding
As of 2026-06-30
- Promoter46.89%
- Public53.11%
1,165 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.59× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #45 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,29,234 Cr | 244.11 | 13.63 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,09,470 Cr | 73.81 | 10.19 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,634 Cr | 269.56 | 7.24 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,513 Cr | 50.7 | 9.37 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,038 Cr | 298.29 | 9.19 | 8.48% | 8.36% |
| Global Health Limited | ₹38,082 Cr | 264.25 | 9.61 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,895 Cr | 136.55 | 9.04 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,496 Cr | 239.03 | 12.55 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹16,888 Cr | 51.6 | 5.44 | 10.37% | 17.18% |
| Rainbow Childrens Medicare Ltd. | ₹15,420 Cr | 62.33 | 9.24 | 16.89% | 16.34% |
| Centenial Surgical Suture Ltd.(this company) | ₹29 Cr | — | 1.09 | -7.72% | -4.1% |
AI analysis
AI-generated · google/gemini-2.5-flashCentenial Surgical Suture Ltd. is listed with a market capitalization of Rs 31 Cr. The company reported revenue of Rs 53.64 Cr and a profit margin of -410.5%. The book value per share is Rs 73.4. Over the last 52 weeks, the share price has ranged from a low of Rs 73.04 to a high of Rs 189.
Positives
- +Promoter holding of 46.8876% indicates a significant stake by the founders.
- +Debt-to-equity ratio is 0.85, indicating a moderate level of debt in relation to equity.
- +No promoter shares are pledged.
Negatives
- −The company reported a negative profit margin of -410.5%.
- −Return on Equity (ROE) is negative at -7.72%.
- −Earnings per share (EPS) in March 2025 was -Rs 4.01.
- −Revenue growth information is not available.
Financial Performance
Centenial Surgical Suture Ltd. reported revenue of Rs 53.6363 Cr in March 2025. This marks a change from Rs 51.3149 Cr in March 2024. The company's net profit in March 2025 was -Rs 1.4636 Cr, compared to Rs 1.1343 Cr in March 2024. The earnings per share (EPS) for March 2025 stood at -Rs 4.01, a decline from Rs 3.11 in March 2024.
Profitability & Returns
The company's profit margin stood at -410.5%. Return on Equity (ROE) was -7.72%, while Return on Capital Employed (ROCE) was 2.1358%. In March 2025, the net profit was -Rs 1.4636 Cr. The company has not provided a dividend yield.
Balance Sheet
The debt-to-equity ratio of Centenial Surgical Suture Ltd. is 0.85. The book value per share is Rs 73.4. No specific details regarding assets or liabilities beyond debt-to-equity are available in the provided data.
Ownership & Pledges
As of June 30, 2026, promoters held 46.8876% of the company's shares. Public shareholding was 53.1124%. There is no reported FII or DII holding. The number of shareholders was 1165. No promoter shares are reported as pledged.
Quarterly Performance
In the quarter ending March 2026, the company reported revenue of Rs 12.58 Cr and a net profit of -Rs 2.31 Cr. This is a decline compared to the December 2025 quarter, where revenue was Rs 14.86 Cr and net profit was Rs 0.15 Cr. EBITDA for March 2026 was -Rs 0.02 Cr.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Centenial Surgical Suture Ltd.share price & fundamentals